Overview of drug
Warnings. Tests before treating
IL23 inhibitor
| Indication | Dose | ||
| Psoriasis | 100 mg administered by subcutaneous injection at Week 0, Week 4, and every 8 weeks thereafter. | ||
| Psoriatic arthritis | 100 mg administered by subcutaneous injection at Week 0, Week 4, and every 8 weeks thereafter. | ||
| Ulcerative colitis | 200 mg administered by IV infusion | ||
| Crohn's disease |
| Common side effects | % | ||
| side effect 1 | # | ||
| Side effect 2 | # | ||
| Side effect 3 | # |